[en] We report the case of a 74-year-old man who suffered for four years from recurrent generalized pustular eruptions associated with acrodermatitis continua of Hallopeau (ACH). Initial therapy using topical corticosteroids, tars and PUVA failed to improve the acral lesions. The disease was also unresponsive to systemic therapy using corticosteroids, methotrexate, etretinate, acitretine and cyclosporin A. Serious side-effects were experienced with these drugs. A marked improvement of the generalized pustules was observed under treatment combining etretinate and methotrexate, without having any effect on the acropustulosis. During hospitalization, a topical tar therapy cleared the pustular rash. Again no effect was observed on the acral lesions. Disulone (DDS) therapy, initiated at a dose of 200 mg/day, completely cleared ACH after 4 weeks. The disease relapsed when the dose was reduced to 100 mg/day. Increasing the DDS to 150 mg/day was rapidly followed by a new clearance of the acral lesions. After a 3-month treatment, the patient has remained lesion free and no DDS-related side-effects have occurred. In conclusion, sulfones may be considered as an alternative therapeutic option in drug-resistant ACH.
Disciplines :
Dermatology
Author, co-author :
Nikkels, Arjen ; Université de Liège - ULiège > Dermatologie
Hallopeau MH. Sur une asphyxie locale des extrémités avec polydactilite suppurative chronique et poussées éphémères de dermatite pustuleuse disséminée et symétrique. Bull Soc Fr Derm Syph 1890; 1: 39-45.
White MI, Main RA. The treatment of Hallopeau's acrodermatitis. Arch Dermatol 1979; 115: 235-6.
Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993; 129: 507-13.
Piraccini BM, Fanti PA, Morrelli R, Tosti A. Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients. Acta Dermatol Venereol 1994; 74: 65-7.
Wilkinson DS. Pustular dermatoses. Br J Dermatol 1969; 81: 38-45.
Pearson LH, Allen BS, Smith JG. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. J Am Acad Dermatol 1984; 11: 755-62.
Konrad K. Acrodermatitis continua suppurativa Hallopeau: Behandlung mit Methotrexate. Hautarzt 1970; 21: 119-23.
Van Dooren-Greebe RJ, van de Kerkhof PCM, Chang A, Happle R. Acitretin monotherapy in acrodermatitis continua Hallopeau. Acta Derm Venereol 1989; 69: 344-6.
Arnold HL. Treatment of Hallopeau's acrodermatitis with triamcinolone acetonide. Arch Dermatol 1978; 114: 963.
Zachariae H, Thestrup-Pedersen K. Cyclosporin A in acrodermatitis continua. Dermatologica 1987; 175: 29-32.
Notowicz A, Stolz E, Heuvel NVD. Treatment of Hallopeau's acrodermatitis with topical mechlorethamine. Arch Dermatol 1978; 114: 123.
Tsuji T, Nishimura M. Topically administered fluorouracil in acrodermatitis continua of Hallopeau. Arch Dermatol 1991; 127: 27-8.
Emtestam L, Wedén U. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol. Br J Dermatol 1996; 135: 644-66.
Mozzanica N, Cattaneo A, The clinical effect of topical calcipotriol in acrodermatitis continua of Hallopeau. Br J Dermatol 1998; 138: 556.
Nguyen VT, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol 1993; 100: 349-55.
